Method Article

An Ex Vivo Explant Model for Studying Glial Interactions in the Mouse Retina

1.9K views

DOI:

10.3791/68482

July 15th, 2025

In This Article

Summary

Here, we provide a detailed methodology for isolating the retina from the mouse eye for extended ex vivo experimentation. This protocol emphasizes making this technically demanding approach accessible for researchers who would like to take advantage of the research avenues afforded by keeping retinal glia in situ in live tissue.

Abstract

The role of glia in glaucoma is an increasingly prominent research topic, but much remains unknown about how populations of these support cells - namely astrocytes and microglia - influence retinal ganglion cell survival. While in vivo and in vitro models provide a degree of insight, both approaches have significant limitations, such as the impact of peripheral immune response in the former and changes to physiological function induced by cell isolation and culture in the case of the latter. To minimize these confounding factors, we have developed an ex vivo retinal explant system in which astrocytes, microglia, and other retinal cell types can be maintained in situ for periods of at least 3 days, enabling targeted investigation at a higher throughput than is typically feasible with in vivo models. Crucially, this approach is highly amenable to methodologies that would be challenging or unfeasible in a living animal yet remains compatible with common downstream assays of intact nervous tissue. Here, we present a protocol suitable for the isolation and culturing of intact retinal explants, along with representative results of immunofluorescence microscopy documenting the changes undergone by glia and retinal ganglion cells in the ex vivo retina.

Introduction

The light sensitive retina, an extension of the central nervous system (CNS) located at the back of the eye, is essential for sight but vulnerable to both acute injury and chronic disease. As with other CNS regions, neurons in the adult retina are not replaced when lost, and the retinal ganglion cells (RGCs) that aggregate and relay visual information to the brain are particularly vulnerable to dysfunction and death in glaucoma, resulting in irreversible vision loss1,2. Glaucoma is a leading cause of blindness worldwide3, yet despite the devastating impact on affected individuals and th....

Access restricted. Please log in or start a trial to view this content.

Protocol

All procedures involving animals were approved by the Institutional Animal Care and Use Committee (IACUC) at Schepens Eye Research Institute (Protocol # 2022N000030, approved 3/4/2025). Animals were handled in accordance with the Association for Research in Vision and Ophthalmology (ARVO) Statement for the Use of Animals in Ophthalmic and Vision Research.

NOTE: Figure 1 shows the key steps in the isolation of live retina from the enucleated mouse eye.

Access restricted. Please log in or start a trial to view this content.

Results

At the macroscopic scale, explanted retinas remain essentially unchanged at both 1- and 3-day time points, although by the latter time they become relatively fragile, necessitating careful handling prior to fixation or other experimental endpoints. Retinas should be relatively flat, without folding (which can result in localized disruption to the diffusion of oxygen and nutrients), and should be suspended in the media between the air-liquid interface and the cell culture insert. By day 3, a faint streak may form on the b.......

Access restricted. Please log in or start a trial to view this content.

Discussion

Organotypic culture32 approaches such as retinal explants harness the experimental flexibility and rapid turnaround time of cell culture while preserving much of the in situ context of in vivo studies, making them a potent avenue for investigating complex interactions between cell types. We present this protocol as an entry point for researchers who may have substantial experience with the eye and be comfortable manipulating a fixed retina but not a fresh one; therefore, we have .......

Access restricted. Please log in or start a trial to view this content.

Disclosures

The authors have nothing to disclose.

Acknowledgements

M.A.M. was supported by NIH/NEI R01EY035312, the Glaucoma Research Foundation Catalyst for a Cure Award, the Melza M. and Frank Theodore Barr Foundation, the Robert M. Sinskey, MD, Foundation, the Ruettgers Family Charitable Foundation, and the B.L. Manger Foundation. P.F.C. was supported by NIH/NEI 2T32EY007145. This work was also enabled by an NIH Core Grant for Vision Research P30 EY003176.  Figure 1 was generated with Biorender. The authors would like to thank Dr. Nasir Uddin for feedback on the manuscript and Dr. Qiurong Zhu for assistance and support.

....

Access restricted. Please log in or start a trial to view this content.

Materials

List of materials used in this article
NameCompanyCatalog NumberComments
#11 Scalpel bladesBard-Parker3,71,311
1 mL pipet ('Pipetman P1000')GilsonF144059M
100 mm Petri dishFalcon351029
16% ParaformaldehydeTed Pella Inc18,505Diluted to 4% for fixation
24 Well PlateFalcon353047For fixation, blocking, and antibody incubation
35 mm Petri dishFalcon351008
6-well plate and insert kitGreiner bio-one657641
Alexa Fluor 488-Donkey Anti-Rabbit IgG (H+L)Jackson ImmunoResearch Laboratories, Inc. 711-545-1521:800 dilution
Alexa Fluor 594 Donkey anti-Rat IgG (H+L) Highly Cross-AdsorbedInvitrogenA-212091:800 dilution
Alexa Fluor 594-F(ab')2 Donkey Anti-Mouse IgG (H+L) Jackson ImmunoResearch Laboratories, Inc. 715-586-1501:800 dilution
Alexa Fluor 647-Donkey Anti-Guinea Pig IgG (H+L)Jackson ImmunoResearch Laboratories, Inc. 706-605-1481:800 dilution
Alexa Fluor 647-F(ab')2 Donkey Anti-Chicken IgY (IgG) (H+L) Jackson ImmunoResearch Laboratories, Inc. 703-606-1551:800 dilution
Angled forceps ('5/45')FST / Dumont11251-35
Anti-Brn3a antibody (mouse)ChemiconMAB15851:200 dilution
Anti-CD206 antibody (rat)BioradMCA22351:200 dilution
Anti-GFAP antibody (chicken)Abcamab46741:1000 dilution
Anti-Iba1 antibody (rabbit)FUJIFILM Wako Pure Chemical Corporation019-197411:500 dilution
Anti-Tmem119 antibody (guinea pig)Synaptic Systems400 0041:500 dilution
B-27, 50xGibco (Thermofisher)17504044
Blunt curved forceps ('Extra Fine Graefe)FST11152-10
Bovine Serum AlbuminSigma-AldrichA9647Use 1% w/v for blocking and antibody incubation
Filter kit (0.2 µm aPES membrane, 150 mL Bottle Top Filter) fisherscientificFB12566508
fine brush, size 3/0princeton art & brush co.06435-1030
GlutaMaxGibco (Thermofisher)35050061
Lab wipes (Kim wipes) KIMTECH34155
N-2, 100xGibco (Thermofisher)17502048
Neurobasal-A Medium, minus phenol redGibco (Thermofisher)12349015
Normal Donkey SerumJackson ImmunoResearch Laboratories, Inc. 017-000-121Use at 10% for blocking and antibody incubation
Penicillin-StreptomycinGibco (Thermofisher)15140122
Pipet Tips, 1000 µLTipOne1126-7810
Spring Scissors ('Cohan-Vannas')FST15000-11
Sterile water ('Dnase, Rnase free')Invitrogen10977-015
Sterile-filtered PBSGibco10010-023
Straight forceps ('mini')FST / Dumont11200-14
Transfer Pipet, 5.8 mLfisherscientific13-711-9AMMD
Triton X-100Thermo Scientific ChemicalsA16046.APUse at 0.5% for blocking and antibody incubation

References

  1. Quigley, H. A. Understanding glaucomatous optic neuropathy: the synergy between clinical observation and investigation. Annu Rev Vis Sci. 2, 235-254 (2016).
  2. Alqawlaq, S., Flanagan, J. G., Sivak, J. M.

Access restricted. Please log in or start a trial to view this content.

Reprints and Permissions

Request permission to reuse the text or figures of this JoVE article

Request Permission

Tags

Retinal Explant ModelNeuroinflammation GlaucomaRetinal Ganglion CellsAstrocyte MicrogliaImmunofluorescence MicroscopyRetinal Cell IsolationEx Vivo RetinaGFAP Expression

Related Articles